Monitor for actual Form 4 or subsequent 144 filings to confirm if the sale proceeds; routine for directors, but worth tracking in context of broader insider activity.
MIRM drugs
MIRM drug pipeline →How the stock moved after the report
NEUTRAL VIEWSTOCK ABOVE ENTRY AT T+60- T+0 · Apr 16 $95.86entry
- T+1 · 7mo ago +2.18%α +0.97% · $97.95
- T+5 · 7mo ago −4.08%α −5.06% · $91.95
- T+20 · 6mo ago +13.87%α +8.06% · $109.16
- T+60 · 4mo ago +24.18%α +17.13% · $119.04
Price Chart
REPLAYWatch the reaction play outHow similar events traded
Executive Summary
Saira Ramasastry, a director at Mirum Pharmaceuticals, filed a Form 144 to notify the sale of 2,000 shares of common stock, valued at approximately $193,800, following a stock option exercise. The shares are intended for sale on or after April 15, 2026.
Key Facts
- Saira Ramasastry is a director at Mirum Pharmaceuticals.
- Filed Form 144 for the proposed sale of 2,000 shares of common stock.
- Shares to be sold following a stock option exercise on April 15, 2026.
- Approximate sale value: $193,800 (based on $96.90/share).
- No immediate sale has occurred; this is a notice of intent to sell.
Financial Impact
Approximately $193,800 in potential proceeds from the sale of 2,000 shares.
Risk Factors
- Perception of insider selling ahead of key catalysts could pressure sentiment, though this is a routine transaction.
- Minimal financial impact given small volume relative to company's $5.8B market cap.
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 3 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 144 Filing (Primary) | 0001950047-26-003474 |
| Document: 0001950047-26-003474-index.html | 0001950047-26-003474 |
| Document: 0001950047-26-003474.txt | 0001950047-26-003474 |
Track record
27 reports on MIRM
5 of 5 bullish or bearish reports moved the stock their way by T+60. Best: +28.29% at T+20 after the Jun 11, 2026 report. 8 of 10 went positive at some point.
Filters
- Nov 16, 2026today SC 13G/A Neutral 3/10 Entry $92.28 Now $91.58 −0.76% settles Feb 12
- Nov 13, 20263d ago Insider Cluster Neutral 3/10 Entry $93.54 Now $91.58 −2.10% settles Feb 12
- Nov 12, 20264d ago 144 Neutral 2/10 Entry $93.33 Now $91.58 −1.88% settles Feb 10
- Nov 10, 20266d ago 8-K Bullish 6/10 Entry $94.42 Now $91.58 −3.01% settles Feb 8
- Nov 4, 202612d ago 144 Neutral 2/10 Entry $93.54 Now $91.58 −2.10% settles Feb 3
- Nov 4, 202612d ago 144 Neutral 2/10 Entry $93.54 Now $91.58 −2.10% settles Feb 3
- Nov 3, 202613d ago 8-K Bullish 6/10 Entry $96.97 Now $91.58 −5.56% settles Feb 2
- Oct 27, 202620d ago Institutional Cluster Mixed 4/10 Entry $85.81 Now $91.58 +6.72% settles Jan 26
- Oct 26, 202621d ago 8-K Bullish 6/10 Entry $85.56 Now $91.58 +7.04% settles Jan 25
- Oct 13, 20264w ago 8-K Bullish 7/10 Entry $79.62 Now $91.58 +15.02% settles Jan 8
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers